Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
268
-
Total 13F shares, excl. options
-
90.3M
-
Shares change
-
+2.9M
-
Total reported value, excl. options
-
$2.12B
-
Value change
-
+$62.5M
-
Put/Call ratio
-
0.42
-
Number of buys
-
147
-
Number of sells
-
-121
-
Price
-
$23.44
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2023
343 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q1 2023.
Guardant Health, Inc. - Common Stock (GH) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.3M shares
of 124M outstanding shares and own 72.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.23M shares), FMR LLC (8.77M shares), Capital International Investors (7.22M shares), BlackRock Inc. (5.9M shares), Temasek Holdings (Private) Ltd (3.66M shares), ALLIANCEBERNSTEIN L.P. (3.3M shares), Clearbridge Investments, LLC (2.7M shares), VIKING GLOBAL INVESTORS LP (2.54M shares), Invesco Ltd. (2.15M shares), and CREDIT SUISSE AG/ (2.15M shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.